Rama Raju D

Aurobindo Pharma Limited - APL Research Centre-I

India

SCHOLARLY PAPERS

1

DOWNLOADS

288

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (1)

1.

Efficacy and Safety of Molnupiravir for the Treatment of Non-Hospitalized Adults With Mild COVID-19: A Randomized, Open-Label, Parallel-Group Phase 3 Trial

Number of pages: 18 Posted: 24 Feb 2022
Aurobindo Pharma Limited - APL Research Centre-I, AXIS Clinicals Limited, Aurobindo Pharma Limited - APL Research Centre-I, Aurobindo Pharma Limited - APL Research Centre-II and Aurobindo Pharma Limited
Downloads 288 (207,905)

Abstract:

Loading...

molnupiravir, efficacy, safety, COVID-19, mild, non-hospitalized, randomized